Trade Report: Today, Beck Mack & Oliver LLC Holds Stake in Omega Healthcare Investors Inc. (OHI)

Today, Beck Mack & Oliver LLC Holds Stake in Omega Healthcare Investors Inc. (OHI)

Beck Mack & Oliver LLC held its position in shares of Omega Healthcare Investors Inc. (NYSE:OHI) during the second quarter, Holdings Channel reports. The fund owned 9,000 shares of the real estate investment trust’s stock at the end of the second quarter. Beck Mack & Oliver LLC’s holdings in Omega Healthcare Investors were worth $306,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Fox Run Management L.L.C. purchased a new position in Omega Healthcare Investors during the second quarter worth approximately $312,000. Bank of Montreal Can purchased a new position in Omega Healthcare Investors during the second quarter worth approximately $6,648,000. Geode Capital Management LLC boosted its position in Omega Healthcare Investors by 4.2% in the first quarter. Geode Capital Management LLC now owns 1,027,524 shares of the real estate investment trust’s stock worth $36,271,000 after buying an additional 41,014 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. boosted its position in Omega Healthcare Investors by 8.3% in the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 75,584 shares of the real estate investment trust’s stock worth $2,612,000 after buying an additional 5,765 shares during the last quarter. Finally, Aviance Capital Management LLC boosted its position in Omega Healthcare Investors by 18.0% in the second quarter. Aviance Capital Management LLC now owns 222,281 shares of the real estate investment trust’s stock worth $7,546,000 after buying an additional 33,980 shares during the last quarter. 83.96% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Inc. (NYSE:OHI) traded up 1.39% during trading on Tuesday, hitting $33.66. 762,714 shares of the stock traded hands. The company has a 50-day moving average price of $35.22 and a 200 day moving average price of $34.38. Omega Healthcare Investors Inc. has a one year low of $26.96 and a one year high of $38.09. The stock has a market cap of $6.51 billion, a PE ratio of 21.13 and a beta of 0.65.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Tuesday, August 2nd. The real estate investment trust reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.04. Omega Healthcare Investors had a return on equity of 7.44% and a net margin of 35.55%. The company earned $228.80 million during the quarter, compared to analysts’ expectations of $181.59 million. During the same period in the prior year, the business earned $0.77 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 14.3% compared to the same quarter last year. Analysts expect that Omega Healthcare Investors Inc. will post $3.39 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 15th. Stockholders of record on Monday, October 31st will be given a $0.61 dividend. This represents a $2.44 annualized dividend and a dividend yield of 7.35%. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Thursday, October 27th. Omega Healthcare Investors’s dividend payout ratio is currently 150.00%.

A number of research firms have recently commented on OHI. Thomas Weisel reissued a “buy” rating and set a $35.85 target price on shares of Omega Healthcare Investors in a research report on Monday, August 1st. JMP Securities cut shares of Omega Healthcare Investors from an “outperform” rating to a “market perform” rating in a report on Thursday, August 18th. They noted that the move was a valuation call. Vetr raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $35.84 price target on the stock in a report on Tuesday, July 12th. Zacks Investment Research raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $39.00 price target on the stock in a report on Wednesday, July 6th. Finally, SunTrust Banks Inc. upped their price target on shares of Omega Healthcare Investors from $38.00 to $42.00 and gave the company a “buy” rating in a report on Thursday, August 4th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $36.96.

In other news, insider Steven J. Insoft sold 5,500 shares of the stock in a transaction that occurred on Monday, September 12th. The stock was sold at an average price of $35.91, for a total value of $197,505.00. Following the completion of the sale, the insider now directly owns 419,081 shares of the company’s stock, valued at $15,049,198.71. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Craig M. Bernfield sold 43,942 shares of the stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $37.47, for a total value of $1,646,506.74. Following the completion of the sale, the director now directly owns 859,995 shares of the company’s stock, valued at $32,224,012.65. The disclosure for this sale can be found here. 4.54% of the stock is owned by insiders.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc (Omega) is a self-administered real estate investment trust (REIT). The Company invests in income producing healthcare facilities, long-term care facilities located throughout the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Related posts

Leave a Comment